Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Assenagon Asset Management S.A. Decreases Stake in Philip Morris International Inc. (NYSE:PM)
Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...
Stocktwits on MSN2d
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...
FDA moves to cut nicotine from cigarettes, in plan first floated under Trump
Zeller credited Gottlieb for advocating for the nicotine regulation within the Trump White House, after the Obama ...
Philip Morris International Inc. stock outperforms competitors on strong trading day
Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
health.wusf.usf.edu1d
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Morningstar4d
Philip Morris International Inc PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Philip Morris confirms FDA authorizes ZYN nicotine pouches
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...